Investigating how heart medications may affect cognitive decline in older adults
Estimating the treatment effect of cardiovascular medications to modify the risk for future cognitive decline in older adults
This study is looking at how heart medications might affect thinking and memory in older adults, with the goal of helping them live better lives as they age.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11192868 on NIH RePORTER |
What this research studies
This research focuses on understanding the effects of cardiovascular medications on cognitive health in older adults. By examining how these treatments may influence the risk of cognitive decline, the study aims to provide insights into improving the quality of life for aging individuals. The research will involve a detailed analysis of patient data and outcomes, utilizing a team of experts in geriatrics and cardiology to ensure robust findings. Patients may be monitored over time to assess changes in cognitive function related to their cardiovascular treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults who are currently prescribed cardiovascular medications and are at risk for cognitive decline.
Not a fit: Patients who are younger than 21 or those not taking cardiovascular medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies that help preserve cognitive function in older adults taking heart medications.
How similar studies have performed: Previous research has shown promising results in understanding the relationship between cardiovascular health and cognitive function, suggesting that this approach may yield valuable insights.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Nanna, Michael — Yale University
- Study coordinator: Nanna, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.